
HBS Reporting
Fauci says vast majority of vaccinated Americans should get a COVID-19 booster
-
HBS Reporting
CDC reports fewer COVID-19 pediatric deaths after data correction
Mar 21, 2022March 18 (Reuters) – The U.S. Centers for Disease Control and Prevention reported 966,575 deaths from...
-
HBS Reporting
Hong Kong leader says plans to review COVID restrictions on Monday
Mar 21, 2022HONG KONG, March 20 (Reuters) – Hong Kong leader Carrie Lam said on Sunday she plans...
-
HBS Reporting
French HAS health authority recommends second Covid-19 booster jab for older people with health risks
Mar 21, 2022PARIS, March 18 (Reuters) – People aged 65 and older with special health risks or conditions...
-
HBS Reporting
U.S. FDA approves Marinus Pharma’s drug to treat seizures; shares jump
Mar 21, 2022March 18 (Reuters) – The U.S. health regulator has approved Marinus Pharmaceuticals Inc’s (MRNS.O) lead drug...
-
HBS Reporting
Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity
Mar 21, 2022March 18 (Reuters) – The following is a summary of some recent studies on COVID-19. They...
-
HBS Reporting
U.S. COVID chief Zients to be replaced by Brown University health expert Jha
Mar 18, 2022WASHINGTON, March 17 (Reuters) – U.S. President Joe Biden on Thursday named public health expert Dr....
-
HBS Reporting
Chinese officials urge elderly to get COVID vaccine, cite lesson of Hong Kong
Mar 18, 2022BEIJING, March 18 (Reuters) – Older people in China should get vaccinated against COVID-19, senior Chinese...
-
HBS Reporting
White House to reopen to public tours as Omicron fades
Mar 17, 2022WASHINGTON, March 15 (Reuters) – The White House will reopen to the public next month after...
-
HBS Reporting
New Zealand PM Ardern announces border reopening earlier than previously signalled
Mar 17, 2022WELLINGTON, March 16 (Reuters) – New Zealand Prime Minister Jacinda Ardern on Wednesday said New Zealand...
-
HBS Reporting
Lilly, Novartis join drugmakers in scaling back operations in Russia
Mar 17, 2022March 15 (Reuters) – A growing number of drugmakers including Eli Lilly and Co (LLY.N), Novartis...